BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)
批准号:
10677141
负责人:
Carlos A. Bacino
金额:
$3.11万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2023-04-30
关键词:
Administrative SupplementAreaBiologicalChargeClinicalClinical MedicineClinical ResearchCommunitiesComplementDiagnosisDiagnosticDiagnostic ProcedureDiseaseEnrollmentEtiologyEvaluationEvaluation ResearchExtramural ActivitiesFibroblastsFundingGeneticGenomic medicineHispanicHistorically Black Colleges and UniversitiesHuman GeneticsHuman ResourcesHybridsInstitutionMedicineModelingMolecular GeneticsNational Center for Advancing Translational SciencesNational Human Genome Research InstituteNetwork-basedParticipantPathway interactionsPatient RecruitmentsPatientsPersonsPhasePhenotypePopulationProceduresProcessProtocols documentationProviderResearchResourcesSiteTechnologyTestingTexasUnderrepresented PopulationsUninsuredUnited States National Institutes of HealthWorkclinical careclinical research sitecollegecostexome sequencinggenetic variantgenome sequencingimprovedinnovationmultiple omicsprogramsrecruitresearch clinical testingstandard of caresuccesstranscriptome sequencingvirtual platform
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
This is an administrative supplement 2 for the Baylor College of Medicine (BCM) Undiagnosed
Diseases Network (UDN) Clinical Site (CS). In years 1-8 of the UDN CS, we provided patients with
undiagnosed diseases (UDD) access to state of the art diagnostic methods, accelerated discovery in
diagnosing and managing UDD, elucidated biological mechanisms of identified genetic variants in disease
causation, leading to potential pathways for improved treatments, and actively engaged the UDN and broader
community to share best practices and technology innovations. We have been among the leading extramural
(non NIH UDP) sites in patient acceptances and completion of in person evaluations, achieving 100% target for
these two key milestones of the program. Of the cases with in-person evaluations completed to date, we have
achieved a 36% solve rate with an additional 12% with strong candidates. We have implemented systematic
RNA sequencing on fibroblasts to complement exome and genome sequencing. We have achieved this by
leveraging an integrated genetics program housed within the Department of Molecular and Human Genetics
(DMHG). We propose to complete years' 1-8 work in year 9 of this second “with cost extension” to be
supported by this proposed administrative supplement. This includes completion of clinical evaluation of
subjects accrued prior to July 1, 2022. We project that we will accept an additional 10 subjects and have
completed evaluation of 10 additional by end of year 9 (June 30, 2022). The Specific Aims are to: 1) Review,
recruit, and evaluate 10 new subjects referred by the UDN coordination center as part of the ongoing NIH UDN
protocol. 2) Integrate this UDN workflow into the broader BCM-specific UDN sustainability plan which is to
establish a streamlined standard operating procedure for the Undiagnosed Diseases Center (UDC) at BCM. 3)
Prioritize under/uninsured and under-represented populations for UDN evaluation by leveraging existing
programs with the same focus for referral and recruitment.
期刊论文(57)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
What Has the Undiagnosed Diseases Network Taught Us About the Clinical Applications of Genomic Testing?
关于基因组检测的临床应用,未确诊疾病网络教会了我们什么?
DOI:
10.1146/annurev-med-042120-014904
发表时间:
2022
期刊:
Annual review of medicine
影响因子:
10.5
作者:
[Murdock,DavidR, Rosenfeld,JillA, Lee,Brendan]
通讯作者:
Lee,Brendan
DOI:
10.1093/hmg/ddw390
发表时间:
2016-12-01
期刊:
Human molecular genetics
影响因子:
3.5
作者:
[Bashamboo A, Donohoue PA, Vilain E, Rojo S, Calvel P, Seneviratne SN, Buonocore F, Barseghyan H, Bingham N, Rosenfeld JA, Mulukutla SN, Jain M, Burrage L, Dhar S, Balasubramanyam A, Lee B, Members of UDN, Dumargne MC, Eozenou C, Suntharalingham JP, de Silva K, Lin L, Bignon-Topalovic J, Poulat F, Lagos CF, McElreavey K, Achermann JC]
通讯作者:
Achermann JC
DOI:
10.1186/s13229-021-00473-3
发表时间:
2021-10-26
期刊:
Molecular autism
影响因子:
6.2
作者:
[Royer-Bertrand B, Jequier Gygax M, Cisarova K, Rosenfeld JA, Bassetti JA, Moldovan O, O'Heir E, Burrage LC, Allen J, Emrick LT, Eastman E, Kumps C, Abbas S, Van Winckel G, Undiagnosed Diseases Network, Chabane N, Zackai EH, Lebon S, Keena B, Bhoj EJ, Umair M, Li D, Donald KA, Superti-Furga A]
通讯作者:
Superti-Furga A
DOI:
10.1002/mgg3.1397
发表时间:
2020-10
期刊:
Molecular genetics & genomic medicine
影响因子:
2
作者:
[Cope H, Spillmann R, Rosenfeld JA, Brokamp E, Signer R, Schoch K, Glanton E, Sullivan JA, Macnamara E, Lincoln S, Golden-Grant K, Undiagnosed Diseases Network, Orengo JP, Clark G, Burrage LC, Posey JE, Punetha J, Robertson A, Cogan J, Phillips JA 3rd, Martinez-Agosto J, Shashi V]
通讯作者:
Shashi V
DOI:
10.1073/pnas.2105228119
发表时间:
2022-02-08
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Huang H, Pan J, Spielberg DR, Hanchard NA, Scott DA, Burrage LC, Dai H, Murdock D, Rosenfeld JA, Mohammad A, Huang T, Lindsey AG, Kim H, Chen J, Ramu A, Morrison SA, Dawson ZD, Hu AZ, Tycksen E, Silverman GA, Baldridge D, Wambach JA, Undiagnosed Diseases Network, Pak SC, Brody SL, Schedl T]
通讯作者:
Schedl T
共 24 条
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)
-
批准号:10205124
-
项目类别:
-
资助金额:$110.0万
-
财政年份:2014
-
负责人:Carlos A. Bacino
-
依托单位:
Expanding and sustaining UDN clinical site operations by leveraging a virtual platform for genetic services delivery
-
批准号:10377271
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2014
-
负责人:Carlos A. Bacino
-
依托单位:
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase III (U01)
-
批准号:10696573
-
项目类别:
-
资助金额:$62.8万
-
财政年份:2014
-
负责人:Carlos A. Bacino
-
依托单位:
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)
-
批准号:9789928
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2014
-
负责人:Carlos A. Bacino
-
依托单位:
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)
-
批准号:10002265
-
项目类别:
-
资助金额:$110.0万
-
财政年份:2014
-
负责人:Carlos A. Bacino
-
依托单位:
Pilot of New Technologies to Increase the Genomic Diagnosis of Undiagnosed Disease Network (UDN) Patients
-
批准号:10377756
-
项目类别:
-
资助金额:$14.99万
-
财政年份:2014
-
负责人:Carlos A. Bacino
-
依托单位:
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase II (U01)
-
批准号:10600465
-
项目类别:
-
资助金额:$78.51万
-
财政年份:2014
-
负责人:Carlos A. Bacino
-
依托单位:
BCM Clinical Site for an Undiagnosed Disease Network (UDN) Phase III (U01)
-
批准号:10905454
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2014
-
负责人:Carlos A. Bacino
-
依托单位:
ANGELMAN SYNDROME NATURAL HISTORY STUDY
-
批准号:8356672
-
项目类别:
-
资助金额:$1.54万
-
财政年份:2010
-
负责人:Carlos A. Bacino
-
依托单位:
ANGELMAN SYNDROME NATURAL HISTORY STUDY
-
批准号:8166673
-
项目类别:
-
资助金额:$2.17万
-
财政年份:2009
-
负责人:Carlos A. Bacino
-
依托单位:
EFFICACY OF A THERAPEUTIC TREATMENT TRIAL IN ANGELMAN SYNDROME
-
批准号:8166677
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2009
-
负责人:Carlos A. Bacino
-
依托单位:
EFFICACY OF A THERAPEUTIC TREATMENT TRIAL IN ANGELMAN SYNDROME
-
批准号:7950622
-
项目类别:
-
资助金额:$0.62万
-
财政年份:2008
-
负责人:Carlos A. Bacino
-
依托单位:
ANGELMAN SYNDROME NATURAL HISTORY STUDY
-
批准号:7950617
-
项目类别:
-
资助金额:$0.86万
-
财政年份:2008
-
负责人:Carlos A. Bacino
-
依托单位:
EFFICACY OF A THERAPEUTIC TREATMENT TRIAL IN ANGELMAN SYNDROME
-
批准号:7605915
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2007
-
负责人:Carlos A. Bacino
-
依托单位:
ANGELMAN SYNDROME NATURAL HISTORY STUDY
-
批准号:7605910
-
项目类别:
-
资助金额:$0.21万
-
财政年份:2007
-
负责人:Carlos A. Bacino
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: